Definitive Healthcare Corp

Definitive Healthcare Corp(DH)股票分析

$1.040

+0.159 (+15.26%)收盘时

Loading chart…
High
1.220
Open
1.020
VWAP
1.09
Vol
8.72M
Mkt Cap
625.05M
Low
1.020
Amount
9.54M
EV/EBITDA, TTM
2.56

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

AI analysis of Definitive Healthcare Corp (DH)

hold

Definitive Healthcare Corp is currently priced at $0.8024, showing a recent 5-day change of +12.37%, which indicates a potential short-term recovery. However, the stock has a concerning RSI of 76.96, suggesting it may be overbought in the short term. Analysts have downgraded their price targets significantly, with Deutsche Bank lowering its target to $1 from $3, indicating a lack of confidence in substantial near-term growth. The main risk is the company's substantial net losses, with a Q1 net income of -$138.6 million, which raises concerns about its long-term viability. Therefore, while there may be short-term gains, the overall outlook suggests holding rather than buying at this time.

估值指标

The current forward P/E ratio for Definitive Healthcare Corp (DH) is 5.00, compared to its 5-year average forward P/E of 44.49.

Forward P/E

Fair
5Y Average P/E
44.49
Current P/E
5.00
高估
92.30
低估
-3.33

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
19.76
Current EV/EBITDA
2.56
高估
37.09
低估
2.43

Forward P/S

Fair
5Y Average P/S
4.55
Current P/S
0.44
高估
8.83
低估
0.26

Alphio AI Price Scenarios for DH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%DH

$3.73

情景价格

B

Base

Base · 50%DH

$3.39

情景价格

B

Bear

Bear · 25%DH

$3.31

情景价格

Whales holding DH

A

Advent International, L.P.

+ HoldingDH

+33.92%

3M Return

事件时间线

2026-09-02 (ET)

09:30:00

Definitive Healthcare Receives Acquisition Interest from Advent International

09:00:00

Definitive Healthcare Appoints Clay Ritchey as New CEO

2026-08-10 (ET)

17:00:00

Consensus 18c Narrows FY26 Revenue Outlook to $220M

16:30:00

Definitive Healthcare Q2 Revenue at $55.2M

16:30:00

Sees Q3 Revenue of $54M-$55M

资讯

DH FAQ — answered by Alphio AI

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo). It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Definitive Healthcare Corp is currently priced at $0.8024, showing a recent 5-day change of +12.37%, which indicates a potential short-term recovery. However, the stock has a concerning RSI of 76.96, suggesting it may be overbought in the short term. Analysts have downgraded their price targets significantly, with Deutsche Bank lowering its target to $1 from $3, indicating a lack of confidence in substantial near-term growth. The main risk is the company's substantial net losses, with a Q1 net income of -$138.6 million, which raises concerns about its long-term viability. Therefore, while there may be short-term gains, the overall outlook suggests holding rather than buying at this time.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始